These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5006547)

  • 21. [Parkinson disease].
    Soins Gerontol; 1999; (19):41-2. PubMed ID: 10745933
    [No Abstract]   [Full Text] [Related]  

  • 22. [Patients with Parkinson disease: help in management of the disease].
    Späte HF; Gemende I; Gemende G
    Z Arztl Fortbild (Jena); 1988; 82(21):1081-3. PubMed ID: 3247791
    [No Abstract]   [Full Text] [Related]  

  • 23. [Between Scylla and Charybdis: drug-induced psychosis in patients with Parkinson disease].
    Kuiper MA; Zwaan WA; Wolters EC
    Ned Tijdschr Geneeskd; 1994 Jul; 138(27):1353-7. PubMed ID: 8035892
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effectiveness of the use of new types of antiparkinson agents].
    Federmann J; Honzáková L; Roth B; Stika L
    Cesk Zdrav; 1981 Jun; 29(6):229-41. PubMed ID: 7261170
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy of parkinsonism].
    Paal G
    Med Welt; 1973 Apr; 24(15):573-6. PubMed ID: 4744982
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined treatment in Parkinson's disease.
    Wheatley D
    Practitioner; 1983 Mar; 227(1377):446-7. PubMed ID: 6889232
    [No Abstract]   [Full Text] [Related]  

  • 27. Choosing a Parkinson Disease Treatment.
    Armstrong MJ; Okun MS
    JAMA; 2020 Apr; 323(14):1420. PubMed ID: 32286645
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of later phases of Parkinson disease].
    Tison F
    Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F85-8. PubMed ID: 18680823
    [No Abstract]   [Full Text] [Related]  

  • 29. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2004 Jun; (11):1736-54. PubMed ID: 15652077
    [No Abstract]   [Full Text] [Related]  

  • 30. Locomotor training in people with Parkinson disease.
    Morris ME
    Phys Ther; 2006 Oct; 86(10):1426-35. PubMed ID: 17012646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ondansetron, a 5-HT3 antagonist for visual hallucinations and paranoid delusional disorder associated with chronic L-DOPA therapy in advanced Parkinson's disease.
    Zoldan J; Friedberg G; Weizman A; Melamed E
    Adv Neurol; 1996; 69():541-4. PubMed ID: 8615178
    [No Abstract]   [Full Text] [Related]  

  • 32. [Statokinesimetric study of the effect of minaprine on tonic postural activity in akineto-hypertonic Parkinson patients].
    Valade D; Baron JB
    Agressologie; 1983 Jan; 24(1):47-55. PubMed ID: 6869694
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
    Pahwa R; Koller WC
    Adv Neurol; 1996; 69():487-91. PubMed ID: 8615169
    [No Abstract]   [Full Text] [Related]  

  • 35. [Parkinsonism].
    Stoliarova LG; Kadykov AS
    Klin Med (Mosk); 1984 May; 62(5):115-20. PubMed ID: 6748569
    [No Abstract]   [Full Text] [Related]  

  • 36. Psychosis in Parkinson's disease: case studies.
    Salter BC; Anderson KE; Weiner WJ
    Neurol Clin; 2006 May; 24(2):363-9. PubMed ID: 16684637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical hazards of the internet: gambling in Parkinson's disease.
    Larner AJ
    Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
    [No Abstract]   [Full Text] [Related]  

  • 38. Levodopa therapy for Parkinson's disease: challenges and future prospects.
    Olanow CW; Lees A; Obeso J
    Mov Disord; 2008; 23 Suppl 3():S495-6. PubMed ID: 18781670
    [No Abstract]   [Full Text] [Related]  

  • 39. [Parkinson disease (paralysis agitans)].
    Povkhovich MV; Baliuk II
    Med Sestra; 1986 May; 45(5):18-21. PubMed ID: 3638466
    [No Abstract]   [Full Text] [Related]  

  • 40. [Addictions, drives and Parkinson's disease].
    Azulay JP
    Rev Neurol (Paris); 2008 Apr; 164(4):308-9. PubMed ID: 18439922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.